aluates Reports

$ 0.0

Automative

Global Oral GLP-1 Market Research Report 2025

Published Date: 2025-05-06

Report Code: QYRE-Auto-22A16263

Global Oral GLP 1 Market Research Report 2023

BUY CHAPTERS

Global Oral GLP-1 Market Research Report 2025

Code: QYRE-Auto-22A16263

Report

2025-05-06

Pages:62

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Oral GLP-1 Market

The global market for Oral GLP-1 was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

The main driving factors for oral GLP-1 receptor agonists are the following:

Market demand: As the number of diabetic patients continues to increase around the world, the demand for diabetes treatment drugs is also growing. As a new type of hypoglycemic drug, oral GLP-1 receptor agonists have high efficacy and good safety, so the market demand is also increasing.

Scientific and technological innovation: With the continuous development of biotechnology, scientists have continued to conduct in-depth research on GLP-1 receptor agonists, and have a deeper understanding of their mechanism of action and pharmacological effects. This provides technical support for the development of oral GLP-1 receptor agonists and promotes the development of this field.

Policy support: Government support and encouragement policies for the pharmaceutical industry provide a good environment for the development and marketing of oral GLP-1 receptor agonists. For example, agencies such as the U.S. Food and Drug Administration (FDA) have provided a fast track for the approval of innovative drugs, accelerating the marketing process of oral GLP-1 receptor agonists.

Capital investment: The research and development of oral GLP-1 receptor agonists requires substantial financial support, including clinical trials, production and marketing. Large pharmaceutical companies and venture capital institutions are increasingly investing in the field of oral GLP-1 receptor agonists, providing funding for the development of this field.

Clinical needs: Traditional diabetes treatment drugs have some side effects and limitations. As a new type of hypoglycemic drug, oral GLP-1 receptor agonists have better tolerance and lower side effects and can meet clinical needs. , improve the treatment effect and quality of life of patients.

This report aims to provide a comprehensive presentation of the global market for Oral GLP-1, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oral GLP-1.

The Oral GLP-1 market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Oral GLP-1 market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Oral GLP-1 companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Oral GLP-1 Market Report

Report Metric	Details
Report Name	Oral GLP-1 Market
Segment by Type	Sitagliptin Saxagliptin Alagliptin Others
Segment by Application	Diabetics Weight Loss People Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Eli Lilly, Novo Nordisk, Pfizer, AstraZeneca, Sanofi
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Oral GLP-1 company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Oral GLP-1 Market report?

Ans: The main players in the Oral GLP-1 Market are Eli Lilly, Novo Nordisk, Pfizer, AstraZeneca, Sanofi

What are the Application segmentation covered in the Oral GLP-1 Market report?

Ans: The Applications covered in the Oral GLP-1 Market report are Diabetics, Weight Loss People, Others

What are the Type segmentation covered in the Oral GLP-1 Market report?

Ans: The Types covered in the Oral GLP-1 Market report are Sitagliptin, Saxagliptin, Alagliptin, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Oral GLP-1 Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Sitagliptin

1.2.3 Saxagliptin

1.2.4 Alagliptin

1.2.5 Others

1.3 Market by Application

1.3.1 Global Oral GLP-1 Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Diabetics

1.3.3 Weight Loss People

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Oral GLP-1 Market Perspective (2020-2031)

2.2 Global Oral GLP-1 Growth Trends by Region

2.2.1 Global Oral GLP-1 Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Oral GLP-1 Historic Market Size by Region (2020-2025)

2.2.3 Oral GLP-1 Forecasted Market Size by Region (2026-2031)

2.3 Oral GLP-1 Market Dynamics

2.3.1 Oral GLP-1 Industry Trends

2.3.2 Oral GLP-1 Market Drivers

2.3.3 Oral GLP-1 Market Challenges

2.3.4 Oral GLP-1 Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Oral GLP-1 Players by Revenue

3.1.1 Global Top Oral GLP-1 Players by Revenue (2020-2025)

3.1.2 Global Oral GLP-1 Revenue Market Share by Players (2020-2025)

3.2 Global Oral GLP-1 Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Oral GLP-1 Revenue

3.4 Global Oral GLP-1 Market Concentration Ratio

3.4.1 Global Oral GLP-1 Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Oral GLP-1 Revenue in 2024

3.5 Global Key Players of Oral GLP-1 Head office and Area Served

3.6 Global Key Players of Oral GLP-1, Product and Application

3.7 Global Key Players of Oral GLP-1, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Oral GLP-1 Breakdown Data by Type

4.1 Global Oral GLP-1 Historic Market Size by Type (2020-2025)

4.2 Global Oral GLP-1 Forecasted Market Size by Type (2026-2031)

5 Oral GLP-1 Breakdown Data by Application

5.1 Global Oral GLP-1 Historic Market Size by Application (2020-2025)

5.2 Global Oral GLP-1 Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Oral GLP-1 Market Size (2020-2031)

6.2 North America Oral GLP-1 Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Oral GLP-1 Market Size by Country (2020-2025)

6.4 North America Oral GLP-1 Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Oral GLP-1 Market Size (2020-2031)

7.2 Europe Oral GLP-1 Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Oral GLP-1 Market Size by Country (2020-2025)

7.4 Europe Oral GLP-1 Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Oral GLP-1 Market Size (2020-2031)

8.2 Asia-Pacific Oral GLP-1 Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Oral GLP-1 Market Size by Region (2020-2025)

8.4 Asia-Pacific Oral GLP-1 Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Oral GLP-1 Market Size (2020-2031)

9.2 Latin America Oral GLP-1 Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Oral GLP-1 Market Size by Country (2020-2025)

9.4 Latin America Oral GLP-1 Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Oral GLP-1 Market Size (2020-2031)

10.2 Middle East & Africa Oral GLP-1 Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Oral GLP-1 Market Size by Country (2020-2025)

10.4 Middle East & Africa Oral GLP-1 Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Eli Lilly

11.1.1 Eli Lilly Company Details

11.1.2 Eli Lilly Business Overview

11.1.3 Eli Lilly Oral GLP-1 Introduction

11.1.4 Eli Lilly Revenue in Oral GLP-1 Business (2020-2025)

11.1.5 Eli Lilly Recent Development

11.2 Novo Nordisk

11.2.1 Novo Nordisk Company Details

11.2.2 Novo Nordisk Business Overview

11.2.3 Novo Nordisk Oral GLP-1 Introduction

11.2.4 Novo Nordisk Revenue in Oral GLP-1 Business (2020-2025)

11.2.5 Novo Nordisk Recent Development

11.3 Pfizer

11.3.1 Pfizer Company Details

11.3.2 Pfizer Business Overview

11.3.3 Pfizer Oral GLP-1 Introduction

11.3.4 Pfizer Revenue in Oral GLP-1 Business (2020-2025)

11.3.5 Pfizer Recent Development

11.4 AstraZeneca

11.4.1 AstraZeneca Company Details

11.4.2 AstraZeneca Business Overview

11.4.3 AstraZeneca Oral GLP-1 Introduction

11.4.4 AstraZeneca Revenue in Oral GLP-1 Business (2020-2025)

11.4.5 AstraZeneca Recent Development

11.5 Sanofi

11.5.1 Sanofi Company Details

11.5.2 Sanofi Business Overview

11.5.3 Sanofi Oral GLP-1 Introduction

11.5.4 Sanofi Revenue in Oral GLP-1 Business (2020-2025)

11.5.5 Sanofi Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

List of Tables

Table 1. Global Oral GLP-1 Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Sitagliptin

Table 3. Key Players of Saxagliptin

Table 4. Key Players of Alagliptin

Table 5. Key Players of Others

Table 6. Global Oral GLP-1 Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Oral GLP-1 Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global Oral GLP-1 Market Size by Region (2020-2025) & (US$ Million)

Table 9. Global Oral GLP-1 Market Share by Region (2020-2025)

Table 10. Global Oral GLP-1 Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 11. Global Oral GLP-1 Market Share by Region (2026-2031)

Table 12. Oral GLP-1 Market Trends

Table 13. Oral GLP-1 Market Drivers

Table 14. Oral GLP-1 Market Challenges

Table 15. Oral GLP-1 Market Restraints

Table 16. Global Oral GLP-1 Revenue by Players (2020-2025) & (US$ Million)

Table 17. Global Oral GLP-1 Market Share by Players (2020-2025)

Table 18. Global Top Oral GLP-1 Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral GLP-1 as of 2024)

Table 19. Ranking of Global Top Oral GLP-1 Companies by Revenue (US$ Million) in 2024

Table 20. Global 5 Largest Players Market Share by Oral GLP-1 Revenue (CR5 and HHI) & (2020-2025)

Table 21. Global Key Players of Oral GLP-1, Headquarters and Area Served

Table 22. Global Key Players of Oral GLP-1, Product and Application

Table 23. Global Key Players of Oral GLP-1, Date of Enter into This Industry

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Oral GLP-1 Market Size by Type (2020-2025) & (US$ Million)

Table 26. Global Oral GLP-1 Revenue Market Share by Type (2020-2025)

Table 27. Global Oral GLP-1 Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 28. Global Oral GLP-1 Revenue Market Share by Type (2026-2031)

Table 29. Global Oral GLP-1 Market Size by Application (2020-2025) & (US$ Million)

Table 30. Global Oral GLP-1 Revenue Market Share by Application (2020-2025)

Table 31. Global Oral GLP-1 Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 32. Global Oral GLP-1 Revenue Market Share by Application (2026-2031)

Table 33. North America Oral GLP-1 Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 34. North America Oral GLP-1 Market Size by Country (2020-2025) & (US$ Million)

Table 35. North America Oral GLP-1 Market Size by Country (2026-2031) & (US$ Million)

Table 36. Europe Oral GLP-1 Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 37. Europe Oral GLP-1 Market Size by Country (2020-2025) & (US$ Million)

Table 38. Europe Oral GLP-1 Market Size by Country (2026-2031) & (US$ Million)

Table 39. Asia-Pacific Oral GLP-1 Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 40. Asia-Pacific Oral GLP-1 Market Size by Region (2020-2025) & (US$ Million)

Table 41. Asia-Pacific Oral GLP-1 Market Size by Region (2026-2031) & (US$ Million)

Table 42. Latin America Oral GLP-1 Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 43. Latin America Oral GLP-1 Market Size by Country (2020-2025) & (US$ Million)

Table 44. Latin America Oral GLP-1 Market Size by Country (2026-2031) & (US$ Million)

Table 45. Middle East & Africa Oral GLP-1 Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 46. Middle East & Africa Oral GLP-1 Market Size by Country (2020-2025) & (US$ Million)

Table 47. Middle East & Africa Oral GLP-1 Market Size by Country (2026-2031) & (US$ Million)

Table 48. Eli Lilly Company Details

Table 49. Eli Lilly Business Overview

Table 50. Eli Lilly Oral GLP-1 Product

Table 51. Eli Lilly Revenue in Oral GLP-1 Business (2020-2025) & (US$ Million)

Table 52. Eli Lilly Recent Development

Table 53. Novo Nordisk Company Details

Table 54. Novo Nordisk Business Overview

Table 55. Novo Nordisk Oral GLP-1 Product

Table 56. Novo Nordisk Revenue in Oral GLP-1 Business (2020-2025) & (US$ Million)

Table 57. Novo Nordisk Recent Development

Table 58. Pfizer Company Details

Table 59. Pfizer Business Overview

Table 60. Pfizer Oral GLP-1 Product

Table 61. Pfizer Revenue in Oral GLP-1 Business (2020-2025) & (US$ Million)

Table 62. Pfizer Recent Development

Table 63. AstraZeneca Company Details

Table 64. AstraZeneca Business Overview

Table 65. AstraZeneca Oral GLP-1 Product

Table 66. AstraZeneca Revenue in Oral GLP-1 Business (2020-2025) & (US$ Million)

Table 67. AstraZeneca Recent Development

Table 68. Sanofi Company Details

Table 69. Sanofi Business Overview

Table 70. Sanofi Oral GLP-1 Product

Table 71. Sanofi Revenue in Oral GLP-1 Business (2020-2025) & (US$ Million)

Table 72. Sanofi Recent Development

Table 73. Research Programs/Design for This Report

Table 74. Key Data Information from Secondary Sources

Table 75. Key Data Information from Primary Sources

Table 76. Authors List of This Report

List of Figures

Figure 1. Oral GLP-1 Picture

Figure 2. Global Oral GLP-1 Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Oral GLP-1 Market Share by Type: 2024 VS 2031

Figure 4. Sitagliptin Features

Figure 5. Saxagliptin Features

Figure 6. Alagliptin Features

Figure 7. Others Features

Figure 8. Global Oral GLP-1 Market Size by Application (2020-2031) & (US$ Million)

Figure 9. Global Oral GLP-1 Market Share by Application: 2024 VS 2031

Figure 10. Diabetics Case Studies

Figure 11. Weight Loss People Case Studies

Figure 12. Others Case Studies

Figure 13. Oral GLP-1 Report Years Considered

Figure 14. Global Oral GLP-1 Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 15. Global Oral GLP-1 Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 16. Global Oral GLP-1 Market Share by Region: 2024 VS 2031

Figure 17. Global Oral GLP-1 Market Share by Players in 2024

Figure 18. Global Top Oral GLP-1 Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral GLP-1 as of 2024)

Figure 19. The Top 10 and 5 Players Market Share by Oral GLP-1 Revenue in 2024

Figure 20. North America Oral GLP-1 Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. North America Oral GLP-1 Market Share by Country (2020-2031)

Figure 22. United States Oral GLP-1 Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Canada Oral GLP-1 Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Oral GLP-1 Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe Oral GLP-1 Market Share by Country (2020-2031)

Figure 26. Germany Oral GLP-1 Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. France Oral GLP-1 Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. U.K. Oral GLP-1 Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Italy Oral GLP-1 Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Russia Oral GLP-1 Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Nordic Countries Oral GLP-1 Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Oral GLP-1 Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Asia-Pacific Oral GLP-1 Market Share by Region (2020-2031)

Figure 34. China Oral GLP-1 Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Japan Oral GLP-1 Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. South Korea Oral GLP-1 Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Southeast Asia Oral GLP-1 Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. India Oral GLP-1 Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Australia Oral GLP-1 Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Oral GLP-1 Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Latin America Oral GLP-1 Market Share by Country (2020-2031)

Figure 42. Mexico Oral GLP-1 Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Brazil Oral GLP-1 Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Oral GLP-1 Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Middle East & Africa Oral GLP-1 Market Share by Country (2020-2031)

Figure 46. Turkey Oral GLP-1 Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Saudi Arabia Oral GLP-1 Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. UAE Oral GLP-1 Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. Eli Lilly Revenue Growth Rate in Oral GLP-1 Business (2020-2025)

Figure 50. Novo Nordisk Revenue Growth Rate in Oral GLP-1 Business (2020-2025)

Figure 51. Pfizer Revenue Growth Rate in Oral GLP-1 Business (2020-2025)

Figure 52. AstraZeneca Revenue Growth Rate in Oral GLP-1 Business (2020-2025)

Figure 53. Sanofi Revenue Growth Rate in Oral GLP-1 Business (2020-2025)

Figure 54. Bottom-up and Top-down Approaches for This Report

Figure 55. Data Triangulation

Figure 56. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions